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Objectives: The aim of this study was designed to test the hypothesis that LTB4 
inactivation could serve as specific control of LTB4-mediated infiltration of human 
neutrophils into ischemic myocardium.  
Background: Leukotriene B4 (LTB4) is not only a lipid chemoattractant mediating the 
recruitment of neutrophils into ischemic tissues, but also activates neutrophils to 
release lysosomal enzymes and to generate reactive oxygen species (ROS). Inhibition 
of LTB4 is a potential therapeutic strategy for interrupting the vicious cycle involving 
progressive recruitment and sustained activation of neutrophils within infarcted 
myocardium. LTB4 12-hydroxydehydrogenase (LTB4DH) converts LTB4 to less 
active metabolite 12-keto-LTB4. Thus, activation of LTB4DH would provide specific 
control of LTB4 activities in neutrophils. METHODS: We induced LTB4DH 
expression by two different active compounds, gallic acid (GA) from Radix Peaonae 
Rubra and the compound RA-C from Radix Astragali, respectively. 
Results: We found that GA and RA-C in combination induced LTB4DH expression in 
a dose and time dependent manner. LTB4DH induction resulted in reduced LTB4 
level, inhibited chemotaxis and enhanced apoptosis in human neutrophils. 
Importantly, co-administration of GA and RA-C significantly reduced infarct size in a 
rat model of myocardial infarction. These results strongly suggest that LTB4DH 
induction is a strategy is to resolve neutrophil-mediated inflammation by enhancing 
the degradation rather than by inhibiting the production of LTB4. Selective 
elimination of LTB4 will allow simultaneous inhibition of the recruitment and 
effective induction of apoptosis of neutrophils, leading to the resolution of neutrophil-
induced inflammation in infarcted myocardium. 
 
